1 Matching Annotations
  1. Feb 2026
  2. www.biorxiv.org www.biorxiv.org
    IL-6R blockade with tocilizumab disrupts pericyte– and tumor cell–driven IL-6/STAT3 signaling, enhancing docetaxel efficacy in ER+ breast cancer
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    biorxiv.org/content/10.64898/2026.01.29.702661v1